187 Pill - yellow round, 9mm
Pill with imprint 187 is Yellow, Round and has been identified as Carbidopa and Levodopa (Orally Disintegrating) 25 mg / 100 mg. It is supplied by Sun Pharmaceuticals.
Carbidopa/levodopa is used in the treatment of parkinson's disease; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 25 mg / 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 187
Carbidopa and Levodopa (Orally Disintegrating)
- Imprint
- 187
- Strength
- 25 mg / 100 mg
- Color
- Yellow
- Size
- 9.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sun Pharmaceuticals
- Inactive Ingredients
-
povidone,
mannitol,
calcium silicate,
crospovidone,
magnesium silicate,
magnesium stearate,
aspartame,
silicon dioxide,
microcrystalline cellulose,
D&C Yellow No. 10,
FD&C Yellow No. 6
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
62756-0187 (Discontinued) | Sun Pharmaceutical Industries Inc. |
47335-0187 | Sun Pharmaceutical Industries Inc. |
Related images for "187"
More about carbidopa / levodopa
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (89)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: dopaminergic antiparkinsonism agents
Patient resources
- Drug Information
- Carbidopa and levodopa enteral
- Carbidopa and levodopa () (Advanced Reading)
- Carbidopa and levodopa (Oral) (Advanced Reading)
- Carbidopa and Levodopa Extended-Release Capsules
Other brands
Sinemet, Rytary, Duopa, Sinemet CR, Parcopa
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.